Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KR.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KR.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.7.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.7.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KR.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.49NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.49NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.192NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.192NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.192NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.39.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.39.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.39.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ME.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ME.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ME.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LE.1.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.49.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.49.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.49.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used